Visual Analog Pain Scale Calculator

The visual analogue scale measures one thing only: the intensity of pain at a moment in time. In its classical paper form it is a 100 mm horizontal line whose left end is labelled no pain and whose right end is labelled worst pain imaginable, with no intermediate marks; the patient places a single stroke on the line and the score is the distance in millimetres from the left anchor. The absence of tick marks is the point, since it stops patients anchoring to round numbers and yields a continuous variable that behaves close to a ratio scale, which is why VAS data tolerate parametric analysis better than ordinal category scales do. The 0 to 10 entries used here are the numeric rating scale equivalent, easier to collect at the bedside and closely correlated with the millimetre version. Widely applied cut-offs on the 100 mm line are 0 to 4 mm for no pain, 5 to 44 mm mild, 45 to 74 mm moderate and 75 to 100 mm severe; on the 0 to 10 form the usual bands are 1 to 3 mild, 4 to 6 moderate and 7 to 10 severe. A change of roughly 13 mm, about 2 points out of 10, or a 30 percent reduction from baseline is the level at which patients typically report meaningful relief. Recording pain at rest, on movement, at its worst and at its best gives more than a single reading does, because a wide spread between best and worst points to incident or breakthrough pain rather than steady background pain. The scale is unidimensional and says nothing about interference, mood or function, and it is unreliable in delirium, advanced dementia and in children under about eight, who need observational tools such as FLACC or a faces scale instead.

Graphic rating lines predate their use in pain. Psychologists including Hayes and Patterson described marking a continuous line to record an attitude in the early 1920s, and the method circulated in personnel and mood research for decades afterwards. Its clinical application to pain took shape after the Second World War, when Kenneth Keele in Britain worked on pain charts for hospital use, and it was formalised in psychiatry by R C B Aitken in 1969 for the measurement of subjective mood states. The instrument that clinicians recognise today comes from rheumatology in the mid-1970s: Edward Huskisson published on the measurement of pain in The Lancet in 1974, and with Jennifer Scott ran the studies that fixed the practical details, including the comparison of vertical against horizontal lines and the demonstration that patients could use the scale reproducibly. The scale spread from rheumatology trials into anaesthesia, emergency medicine and oncology because it produced a number that could be averaged across a trial arm. During the 1990s it became institutional: the American Pain Society promoted the idea of pain as a fifth vital sign, the Veterans Health Administration adopted routine numeric pain screening at the end of that decade, and accreditation standards followed. The consequences were mixed. Routine scoring did improve recognition of untreated pain, but treating a target number rather than a patient contributed to the pattern of opioid escalation later criticised in North America, and by the late 2010s several bodies had stepped back from mandatory numeric pain screening while keeping the scale as a research and monitoring tool.